Advertisement
Screener

AYTU BIOPHARMA, INC (AYTU) Form 10-K: Annual report

AYTU BIOPHARMA, INC Form 10-K: Annual report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-09-22: Form 10-K; Period of report 2026-06-30; Description FORM 10-K; Document aytu20260630_10k.htm.
  • 2025-09-23: Form 10-K; Period of report 2025-06-30; Description FORM 10-K; Document aytu20250630c_10k.htm.
  • 2024-09-26: Form 10-K; Period of report 2024-06-30; Description FORM 10-K; Document aytu20240630_10k.htm.
  • 2023-10-12: Form 10-K; Period of report 2023-06-30; Description 10-K; Document aytu-20230630x10k.htm.
FiledFormPeriod of reportDescriptionDocument
2026-09-2210-K2026-06-30FORM 10-Kaytu20260630_10k.htm
2025-09-2310-K2025-06-30FORM 10-Kaytu20250630c_10k.htm
2024-09-2610-K2024-06-30FORM 10-Kaytu20240630_10k.htm
2023-10-1210-K2023-06-3010-Kaytu-20230630x10k.htm
2022-09-2710-K2022-06-3010-Kaytu-20220630x10k.htm
2021-09-2810-K2021-06-3010-Kaytu-20210630x10k.htm
2020-10-0610-K2020-06-30ANNUAL REPORTaytu_10k.htm
2019-09-2610-K2019-06-30ANNUAL REPORTaytu_10k.htm
2018-09-0610-K2018-06-30ANNUAL REPORTf10k2018_aytubioscience.htm
2017-08-3110-K2017-06-30FORM 10-Kv473641_10k.htm
2016-09-0110-K2016-06-30FORM 10-Kv447436_10k.htm
2015-09-2810-K2015-06-3010-Kd85936d10k.htm
2014-11-2610-K2014-08-31ANNUAL REPORTrosewind10k8312014.htm
2013-11-2610-K2013-08-31ANNUAL REPORTrswnd_10k8312013.htm
2012-11-2910-K2012-08-31ANNUAL REPORTrswnd_10k8312012.htm
2011-11-2910-K2011-08-31ANNUAL REPORT FOR YEAR ENDED 8-31-2010rswn_10k.htm
2010-11-2310-K2010-08-31ANNUAL REPORT FOR YEAR ENDED 8-31-2010rosewind10k83110_11192010.htm
2009-10-2010-K2009-08-31ANNUAL REPORT FOR YEAR ENDED 8-31-2009rosewind10k83109_10122009.htm
2008-11-1210-K2008-08-31ANNUAL REPORT FOR YEAR ENDED 8-31-2008rosewindfye10k83108_11708.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77